EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diffusion-Weighted MRI as a Quantitative Imaging Biomarker in Colon Tumors

Peter Obel Otto, Martina Kastrup Loft, Søren Rafael Rafaelsen iD, Malene Roland Vils Pedersen iD

Cancers · 27.12.2023 · 16 (1) · 144

DOI: 10.3390/cancers16010144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 27.12.2023. Verfasst von Peter Obel Otto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital of Southern Denmark, Beriderbakken 4, 7100 Vejle, Denmark. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by Lillebaelt Research Council, Vejle Hospital, Denmark., Lillebaelt Research Council, Vejle Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the use of quantitative diffusion-weighted MRI (DW-MRI) as a diagnostic imaging biomarker in differentiating between benign colon adenoma, early, and advanced cancer of the colon, as well as predicting lymph node involvement, and finally comparing mucinous-producing colon cancer with adenomas and non-mucinous colon cancer.

Method

Patients with a confirmed tumor on colonoscopy were eligible for inclusion in this study. Using a 3.0 Tesla MRI machine, the main tumor mean apparent diffusion coefficient (mADC) was obtained. Surgically resected tumor specimens served as an endpoint, except in mucinous colon cancers, which were classified based on T2 images.

Results

A total of 152 patients were included in the study population. The mean age was 71 years. A statistically significant mADC mean difference of −282 × 10−6 mm2/s [−419–−144 95% CI, p < 0.001] was found between colon adenomas and early colon cancer, with an AUC of 0.80 [0.68–0.93 95% CI] and an optimal cut off value of 1018 × 10−6 mm2/s. Only a small statistically significant difference (p = 0.039) in mADC was found between benign tumors and mucinous colon cancer. We found no statistical difference in mADC mean values between early and advanced colon cancer, and between colon cancer with and without lymph node involvement.

Conclusion

Quantitative DW-MRI is potentially useful for determining whether a colonic tumor is benign or malignant. Mucinous colon cancer shows less diffusion restriction when compared to non-mucinous colon cancer, a potential pitfall.

Schlagwörter

Stichwörter der Autor:innen

ADCDWIMRIadenomacolon cancerdiffusion weighted imagingmucinous

Autor:innen und Institutionen

  • Department of Radiology, University Hospital of Southern Denmark, Beriderbakken 4, 7100 Vejle, Denmark.
  • Danish Colorectal Cancer Center South, Vejle Hospital, 7100 Vejle, Denmark.
  • Department of Regional Health Research, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.

ORCID-Profile: Søren Rafael Rafaelsen, Malene Roland Vils Pedersen

Förderung

  • This research was funded by Lillebaelt Research Council, Vejle Hospital, Denmark.
  • Lillebaelt Research Council, Vejle Hospital

Zitieren

APA

Otto, P. O., Loft, M. K., Rafaelsen, S. R., & Pedersen, M. R. V. (2023). Diffusion-Weighted MRI as a Quantitative Imaging Biomarker in Colon Tumors. Cancers, 16(1), 144. https://doi.org/10.3390/cancers16010144

Vancouver

Otto PO, Loft MK, Rafaelsen SR, Pedersen MRV. Diffusion-Weighted MRI as a Quantitative Imaging Biomarker in Colon Tumors. Cancers. 2023;16(1):144. doi:10.3390/cancers16010144

BibTeX
@article{Otto2023,
  author = {Otto, Peter Obel and Loft, Martina Kastrup and Rafaelsen, Søren Rafael and Pedersen, Malene Roland Vils},
  title = {Diffusion-Weighted MRI as a Quantitative Imaging Biomarker in Colon Tumors},
  journal = {Cancers},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {144},
  doi = {10.3390/cancers16010144}
}
Kostenlos starten →